196 related articles for article (PubMed ID: 18505139)
1. Estrogen receptor expression in melasma: results from facial skin of affected patients.
Lieberman R; Moy L
J Drugs Dermatol; 2008 May; 7(5):463-5. PubMed ID: 18505139
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis.
Jang YH; Lee JY; Kang HY; Lee ES; Kim YC
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1312-6. PubMed ID: 20337826
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma.
Bak H; Lee HJ; Chang SE; Choi JH; Kim MN; Kim BJ
Dermatol Surg; 2009 Aug; 35(8):1244-50. PubMed ID: 19438666
[TBL] [Abstract][Full Text] [Related]
4. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women.
Tamega Ade A; Miot HA; Moço NP; Silva MG; Marques ME; Miot LD
Int J Cosmet Sci; 2015 Apr; 37(2):222-8. PubMed ID: 25439299
[TBL] [Abstract][Full Text] [Related]
5. The dermal stem cell factor and c-kit are overexpressed in melasma.
Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
[TBL] [Abstract][Full Text] [Related]
6. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.
Miot LD; Miot HA; Polettini J; Silva MG; Marques ME
Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990
[TBL] [Abstract][Full Text] [Related]
7. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
[TBL] [Abstract][Full Text] [Related]
8. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.
Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B
Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614
[TBL] [Abstract][Full Text] [Related]
9. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
[TBL] [Abstract][Full Text] [Related]
10. [Facial melanosis (melasma)].
Witkiewicz IM; Neering H
Ned Tijdschr Geneeskd; 1981 Apr; 125(16):609-11. PubMed ID: 7242709
[TBL] [Abstract][Full Text] [Related]
11. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
12. Extra-facial melasma: clinical, histopathological, and immunohistochemical case-control study.
Ritter CG; Fiss DV; Borges da Costa JA; de Carvalho RR; Bauermann G; Cestari TF
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1088-94. PubMed ID: 22827850
[TBL] [Abstract][Full Text] [Related]
13. Molecular structure and concentration of melanin in the stratum corneum of patients with melasma.
Moncada B; Sahagún-Sánchez LK; Torres-Alvarez B; Castanedo-Cázares JP; Martínez-Ramírez JD; González FJ
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):159-60. PubMed ID: 19438997
[TBL] [Abstract][Full Text] [Related]
14. Melasma in men: a clinical, aetiological and histological study.
Sarkar R; Puri P; Jain RK; Singh A; Desai A
J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):768-72. PubMed ID: 20015053
[TBL] [Abstract][Full Text] [Related]
15. Melasma and other skin manifestations or oral contraceptives.
Resnik SS
Trans N Engl Obstet Gynecol Soc; 1967; 21():101-7. PubMed ID: 5620604
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and awareness of melasma during pregnancy.
Moin A; Jabery Z; Fallah N
Int J Dermatol; 2006 Mar; 45(3):285-8. PubMed ID: 16533230
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
[TBL] [Abstract][Full Text] [Related]
18. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women.
Tamega Ade A; Miot LD; Bonfietti C; Gige TC; Marques ME; Miot HA
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):151-6. PubMed ID: 22212073
[TBL] [Abstract][Full Text] [Related]
19. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma.
Tannous ZS; Astner S
J Cosmet Laser Ther; 2005 Mar; 7(1):39-43. PubMed ID: 16020216
[TBL] [Abstract][Full Text] [Related]
20. There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study.
Kaya AH; Ulus A; Bayri Y; Topal A; Gun S; Kandemir B; Dagcinar A; Senel A; Iyigun O
Surg Neurol; 2009 Sep; 72(3):263-5; discussion 265. PubMed ID: 19147189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
